PE/Dazzle™ 594 anti-human CD4 317448 from BioLegend

Product Specs
ItemPE/Dazzle™ 594 anti-human CD4
CompanyBioLegend
Price $304.00Supplier Page View Company Product Page
Catalog Number317448
Quantity100 tests
ApplicationsFC - Quality tested
Conjugate/TagPE/Dazzle™ 594
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
ReactivityHuman, Cynomolgus, Rhesus
IsotypeMouse IgG2b, kappa
CloneOKT4
HostMouse
Antibody TypePrimary
ImmunogenHuman peripheral T cells
TargetCD4
NCBI Full Gene NameCD4 molecule
NCBI Gene AliasesCD4mut, IMD79, Leu-3, OKT4D, T4
ClonalityMonoclonal

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Epidermal and Dermal T Cells Exhibit Distinct Proteomic SignaturesInt J Mol SciAugust 18, 2025Amalie Arvesen, Marcel B. M. Teunissen, Sofie Agerbæk, Bjørn Kromann, Line Bruun Pilgaard Møller, Ahmed Gehad, Rachael A. Clark, Marianne Bengtson Løvendorf, Beatrice Dyring-AndersenBD Biosciences, and BV421-conjugated FcεRIa (1:100, AER-37, 334624), PE-Dazzle594–conjugated CD4 (1:200, OKT4, 317448), BV605–conjugated CD3 (1:100, OKT3, 317322) from BioLegend. DTs were identified by their CD45+CD3+

(2) Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-diseaseFrontiers in immunologyJanuary 1, 2022Gilman KE, Cracchiolo MJ, Matiatos AP, Davini DW, Simpson RJ, Katsanis E.(CD3, clone UCHT1, Biolegend no. 300429 or 300415), anti-human CD4 (CD4, clone OKT4, Biolegend no. 317447 or 317418), anti-human CD8 (CD8, clone RPA-T8, Biolegend no. 301045 or 301012), anti-human CCR7 (CCR7,

(3) ILC3s control airway inflammation by limiting T cell responses to allergens and microbesCell reportsNovember 23, 2021Teng F, Tachó-Piñot R, Sung B, Farber DL, Worgall S, Hammad H, Lambrecht BN, Hepworth MR, Sonnenberg GF.AB_2722575" CD3-PE-Cy7 (UCHT1),BioLegend,"Cat# 300420, RRID: AB_439781" CD4-PE-Dazzle 594 (OKT4),BioLegend,"Cat# 317448, RRID: AB_2565847" CD5-PE-Cy7 (UCHT2),BioLegend,"Cat# 300622, RRID: AB_2275812" CD11b-Alexa Fluor

(4) Spatially and cell-type resolved quantitative proteomic atlas of healthy human skinNature communicationsNovember 5, 2020Dyring-Andersen B, Løvendorf MB, Coscia F, Santos A, Møller LBP, Colaço AR, Niu L, Bzorek M, Doll S, Andersen JL, et al.BV421-conjugated FcεRIa (1:100, AER-37, 334624, BioLegend), PE/Dazzle594-conjugated CD4 (1:200, OKT4, 317448, BioLegend), PE-Cy7-conjugated CD8 (1:100, RPA-T8, 557746, BD Pharmingen), PE-conjugated CD11b (1:100,

(5) Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell ResponsesImmunityOctober 13, 2020Zhou R, To KK, Wong YC, Liu L, Zhou B, Li X, Huang H, Mo Y, Luk TY, Lau TT, et al.CD3 (OKT3),Biolegend,Cat# 317330; RRID: AB_2563507 PE-Dazzle594 anti-human CD4 (OKT4),Biolegend,Cat# 317448; RRID: AB_2565847 APC-Fire750 anti-human CD8 (SK1),Biolegend,Cat# 344746; RRID: AB_2572095 BV421 anti-human

(6) Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLLNature communicationsJanuary 29, 2020Rendeiro AF, Krausgruber T, Fortelny N, Zhao F, Penz T, Farlik M, Schuster LC, Nemc A, Tasnády S, Réti M, et al.

(7) Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinomaCancer immunology, immunotherapy : CIIJuly 1, 2019Ludwig S, Hong CS, Razzo BM, Fabian KPL, Chelvanambi M, Lang S, Storkus WJ, Whiteside TL.reactive against the following target molecules CD4 (PE/Dazzle 594, Clone OKT4, Biolegend, Cat. no: 317448), CD11b (APC, Clone M1/70, Thermo Fisher, Cat. no: 17–0112-81), FoxP3 (APC, Clone FJK-16 s, ThermoFisher,

(8) Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primatesJournal of immunology (Baltimore, Md. : 1950)June 15, 2010Cicin-Sain L, Smyk-Pearson S, Currier N, Byrd L, Koudelka C, Robinson T, Swarbrick G, Tackitt S, Legasse A, Fischer M, et al.

(9) Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor functionJournal of translational medicineOctober 22, 2009Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM, Manjili MH.

Be the First to Write a Review!

PE/Dazzle™ 594 anti-human CD4 from BioLegend

Description

BioLegend

Citations (9)

Reviews

PE/Dazzle™ 594 anti-human CD4 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map